cefoperazone has been researched along with cefotaxime in 181 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 138 (76.24) | 18.7374 |
| 1990's | 15 (8.29) | 18.2507 |
| 2000's | 20 (11.05) | 29.6817 |
| 2010's | 8 (4.42) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albrecht, HA; Beskid, G; Christenson, JG; Georgopapadakou, NH; Keith, DD; Konzelmann, FM; Pruess, DL; Rossman, PL; Wei, CC | 1 |
| Albrecht, HA; Beskid, G; Christenson, JG; Deitcher, KH; Georgopapadakou, NH; Keith, DD; Konzelmann, FM; Pruess, DL; Wei, CC | 1 |
| Babu, E; Endou, H; Narikawa, S; Takeda, M | 1 |
| Chairoungdua, A; Choi, BK; Endou, H; Jung, KY; Kim, DK; Kusuhara, H; Narikawa, S; Sekine, T; Shimoda, M; Sugiyama, Y; Takeda, M; Tojo, A | 1 |
| Anzai, N; Babu, E; Endou, H; Enomoto, A; Huang, XL; Khamdang, S; Narikawa, S; Noshiro, R; Onozato, ML; Piyachaturawat, P; Takeda, M; Tojo, A | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Ayala, JA; Casellas, JM; Di Conza, J; Ghiglione, B; Gutkind, G; Power, P; Radice, M; Rodríguez, MM | 1 |
| Kwon, DH; Lu, CD | 1 |
| Hsiao, YJ; Hu, RM; Huang, KJ; Wu, LT; Yang, TC | 1 |
| Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
| Cai, JC; Chen, GX; Zhang, R; Zhou, HW | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Arakawa, Y; Ishikawa, K; Nagano, N; Nagano, Y; Wachino, J | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Ichiishi, S; Mikamo, H; Nakao, K; Shibata, T; Tanaka, K; Watanabe, K | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, JY; Ko, KS; Lee, MY; Park, YK; Peck, KR; Rhee, JY; Shin, JY; Song, JH | 1 |
| Collins, B; Cotter, PD; Curtis, N; Hill, C; Ross, RP | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Bommareddy, A; Gionfriddo, MR; Heindel, GA; Mukhija, P; Vanwert, AL; Witkowski, S; Wolman, AT | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Palillo, ES; Salleh, MA | 1 |
| Matthias, FR; Schäfer, H | 1 |
| Acar, JF; Denis, F; Drugeon, H; Fleurette, J; Kazmierczak, A; Siebor, E; Sirot, J; Soussy, CJ; Thabaut, A | 1 |
| Allington, DR; Chandler, MH; Pennell, AT | 1 |
| Choong, FP; Hussain, ZA; Lee, YH | 1 |
| Hasegawa, S; Hattori, R; Kinukawa, T; Matsuura, O; Ohshima, S; Ono, Y; Takeuchi, N | 1 |
| Adam, D; Naber, K; Schäfer, H | 1 |
| Durgham, SM; Ishag, AH; Shibl, AM | 1 |
| Lingaas, E; Midtvedt, T | 1 |
| Berger, SA; Dan, M; Gorea, A; Krispin, M; Levenberg, A; Serour, F | 1 |
| Ishikawa, S; Shinagawa, N; Tachi, Y; Yura, J | 1 |
| Ecari, U; Fantoni, U; Ruffilli, MP | 1 |
| Ando, M; Horisawa, M; Iriyama, K; Ishikawa, S; Kataoka, M; Kondo, T; Masaoka, A; Shinagawa, N; Suzuki, H; Yura, J | 1 |
| Drusano, G; McNamee, W; Ryan, P; Schimpff, S; Standiford, H; Tatem, B | 1 |
| Noel, GJ; Teele, DW | 1 |
| Donato, JB; Joseph, WS; LeFrock, JL; McCloskey, RV; Smith, BR; Weber, SJ | 1 |
| Neiderriter, K; Norden, CW | 1 |
| Hazumi, N; Matsuda, K; Nakagawa, S; Sanada, M; Tanaka, N | 1 |
| Aonuma, S; Hayashi, I; Konno, K; Oizumi, K | 1 |
| Nakamura, M; Nakashio, S | 1 |
| Johnson, JT; Yu, VL | 1 |
| Arione, R; Di Nola, F; Marietti, G | 1 |
| Ikeda, Y; Nishino, T; Tanino, T | 1 |
| Tural, D; Willke, A | 1 |
| Imanaka, M; Matsumoto, M; Ogita, S; Oka, T; Sugawa, T | 1 |
| Arai, T | 1 |
| Asari, S; Hayashi, C; Horikawa, M; Kouda, K; Miyai, K; Tsukamoto, H | 1 |
| Echols, RM; Hamilton, RA; Kowalsky, SF; McCormick, EM | 1 |
| Carson, PB; Moritz, VA | 1 |
| Hikida, M; Inoue, M; Mitsuhashi, S | 1 |
| Barry, AL; Fuchs, PC; Jones, RN | 1 |
| Howell, AW; Jorgensen, JH; Redding, JS | 1 |
| Inouye, S; Ito, T; Kazuno, Y; Murata, S; Shomura, T; Yoshida, T | 1 |
| Chin, NX; Labthavikul, P; Neu, HC; Saha, G | 1 |
| Jones, RN; Wojeski, WV | 1 |
| Cowles, LS; Johnson, JD; Raff, MJ; Reid, KH; Shields, CB | 1 |
| Barry, AL; Jones, RN; Thornsberry, C | 2 |
| Charles, D; Larsen, B | 1 |
| Birk, RJ; Kurzynski, TA; Toohey, KL; Zabransky, RJ | 1 |
| Ma, MY; Rho, JP | 1 |
| Hirano, F; Inouye, S; Kazuno, Y; Nishino, T; Watanabe, T | 1 |
| Fujimoto, M; Sakai, K; Ueda, T | 1 |
| Yoshikawa, T | 1 |
| Adams, CR; Anderson, EL; Robinson, PA; Tu, KK | 1 |
| Chin, NX; Labthavikul, P; Neu, HC | 1 |
| Marsh, TD | 1 |
| Bies, M; Buck, RE; Chisholm, DR; Kessler, RE; Leitner, F; Misiek, M; Price, KE; Pursiano, TA; Tsai, YH | 1 |
| Barry, AL; Fuchs, PC; Jones, RN; Thornsberry, C | 1 |
| Norrby, SR | 1 |
| Bryskier, A; Le Noc, D; Le Noc, P | 1 |
| Barza, M; Noble, JT | 1 |
| Jones, RN | 1 |
| Goto, S; Hasebe, S; Kanno, H; Ozaki, K; Sato, K; Takagi, T; Tomizawa, M; Tsuji, A; Yakata, M; Yatagai, S | 1 |
| Chu, KW; Fan, ST; Lau, WY; Suen, HC; Wong, KK; Yiu, TF | 1 |
| Barriere, SL; Mordenti, J; Ozasa, DC | 1 |
| Hernández, NI; Nevárez, M; Ramírez-Ronda, CH; Rodríguez, JR | 1 |
| Guenthner, SH; Norris, SM; Wenzel, RP | 1 |
| Inamori, Y; Kato, Y; Kubo, M | 1 |
| DeVito, JM; John, JF | 1 |
| Havlík, J; Maresová, V | 1 |
| Bourne, DW; Cao, GR; English, PB; Filippich, LJ; Guerrini, VH | 1 |
| Ayers, LW; Gavan, TL; Gerlach, EH; Jones, RN; Sommers, HM | 1 |
| Aber, RC; Al-Mondhiry, HA; Caputo, GM; Weitekamp, MR | 1 |
| Allerberger, F; Guggenbichler, JP; Kofler, J | 1 |
| Ikeda, S; Ishibashi, A; Koshiba, K | 1 |
| Drusano, GL; Koch, TR; Kroll, MH; Warren, JW | 1 |
| Arai, S; Fujimoto, K; Goto, S; Kasai, K; Masuyoshi, S; Miyazaki, S; Tsuji, A | 1 |
| Hiraoka, T; Nakakuma, K; Ogata, K; Ootsuka, K; Tashiro, S | 1 |
| File, TM; Salstrom, SJ; Tan, JS | 1 |
| Garcia-Rodriguez, JA; Gomez-Garcia, AC | 1 |
| Guggenbichler, JP; Kofler, J | 1 |
| Aikawa, N; Ishibiki, K | 1 |
| Chiarini, F; Del Piano, M; La Palombara, P; Nicosia, R | 1 |
| Drusano, GL; McNamee, W; Standiford, HC; Tatem, BA | 1 |
| Bégué, P; Lasfargues, G; Quinet, B; Quiniou, F; Safran, C | 1 |
| Brenciaglia, MI; Cipriani, P; Filadoro, F; Ghezzi, MC; Giordano, A; Mancini, C; Rivanera, D | 1 |
| Concia, E; Marino, P; Marone, P; Verani, D | 1 |
| Iegri, F; Lorenzi, A; Mascellino, MT; Prignano, G | 1 |
| Inoue, M; Katsu, K; Kitoh, K; Mitsuhashi, S | 1 |
| Aznar, J; Borobio, MV; Garcia, F; Jimenez, R; Perea, EJ | 1 |
| Gerding, DN; Hall, WH; Opfer, BJ | 1 |
| Durack, DT; Lang, SD | 1 |
| Garcia-Rodriguez, JA | 1 |
| Belmega, D; Jendroschek, H; Kemmerich, B; Koeppe, P; Lode, H | 1 |
| Baker, CN; Jones, RN; Thornsberry, C | 1 |
| Durack, DT; Edwards, DJ; Lang, SD | 1 |
| Hewitt, WL; Hindler, JA; Kurtz, TO; Martin, WJ; Winston, DJ; Young, LS | 1 |
| Bryk, DA; Panwalker, AP; Trager, GM; White, GW; Zimelis, VM | 1 |
| Loock, CA; McCracken, GH; Schaad, UB; Thomas, ML | 1 |
| Gilchrist, MJ; Spelhaug, DR; Washington, JA | 1 |
| Cherubin, CE; Corrado, ML; Landesman, SH | 1 |
| Durosoir, JL; Saliou, P; Thabaut, A | 1 |
| Durack, DT; Perfect, JR | 2 |
| Fu, KP; Neu, HC | 2 |
| McCloskey, RV; Trent, JA; Tutlane, VA | 1 |
| Slack, MP | 1 |
| Fox, JM; Quall, CO; Woolfrey, BF | 1 |
| Livermore, DM; Williams, JD; Williams, RJ | 1 |
| Forsgren, A | 1 |
| Chow, AW; Drulak, MW | 1 |
| LeFrock, JL; Miller, MA; Vercler, MJ | 1 |
| Brogard, JM; Comte, F | 1 |
| Weinstein, AJ | 1 |
| Braveny, I; Elsser, R; Machka, K | 1 |
| Grimm, L; McCracken, GH; Nelson, JD | 1 |
| Labthavikul, P; Neu, HC | 1 |
| Neu, HC | 2 |
| Neu, HC; Prince, AS | 1 |
| Ahonkhai, VI; Cherubin, CE; Shulman, MA; Sierra, MF | 1 |
| Kawakita, J; Kawamura, N; Ohkoshi, M; Okada, K; Satake, Y | 1 |
| Peters, G; Pulverer, G | 1 |
| Craig, WA; Greenfield, RA; Kurzynski, TA | 1 |
| Chanal, M; Cluzel, R; Glanddier, Y; Sirot, D; Sirot, J | 1 |
| Baumgärtner, M; Grehn, M; Wundt, W | 1 |
| Drew, WL; Mintz, L | 1 |
| Ernest, KD; Magnussen, CR; Sammartino, MT | 1 |
| Fujimura, H; Nozaki, M; Okada, K; Tsurumi, K; Yanagihara, M | 1 |
| Bergeron, MG; Simard, P | 1 |
| Dunlop, WE; Fabian, TC; Stone, HH; Strom, PR | 1 |
| Nightingale, CH; Quintiliani, R | 1 |
| Belmega, G; Borner, K; Jendroschek, T; Kemmerich, B; Koeppe, P; Lode, H | 1 |
| Fujimoto, S; Furuta, I; Harikane, O; Hiromatsu, K; Iimori, M; Kamiki, T; Kodama, J; Kotera, K; Maejima, K; Masutani, T; Matsunaga, K; Miwatani, T; Nishimura, T; Nukina, M; Shimizu, Y; Tabuki, K; Takahashi, M; Takashima, E; Takashima, T; Takeda, Y; Tanaka, M; Yabuuchi, E; Yamanaka, K; Yoshizaki, E | 1 |
| Marks, MI | 1 |
| Garzone, P; Lyon, J; Yu, VL | 1 |
| Agostini, M; Barlocco, G; Bonomi, U; Borgo, G; Bozzino, L; Cabrini, G; Cappelletti, LM; Castellani, L; Conforti, M; Mastella, G | 1 |
| LeBel, M; Lewis, GP; Paone, RP | 1 |
| Meyer, RD; Pasiecznik, K | 1 |
| Cohen, SH; Demling, R; Franti, CE; Gunther, R; Hoeprich, PD; Merry, JM; Miner, DJ | 1 |
| Diven, WF; Johnson, JT; Muder, RR; Myers, EN; Thearle, PB; Yu, VL | 1 |
| Frongillo, RF; Galuppo, L; Moretti, A | 1 |
| Jones, RN; Wilson, HW | 1 |
| Monteil, H; Peladan, F; Zinsius, M | 1 |
| Minami, S; Nakashima, H; Saikawa, I; Watanabe, Y; Yasuda, T; Yotsuji, A | 1 |
| Hayashi, T; Kasuga, C; Kumano, K; Nishida, N; Saikawa, I; Watanabe, Y; Yasuda, T | 1 |
| Lindridge, MA; Livermore, DM; Said, AA; Williams, JD; Williams, RJ | 1 |
| Reddy, J | 1 |
| Accornero, L; Bacigalupo, A; Carella, AM; Congiu, AM; Costa, G; Occhini, D; Santini, G; Sbaffi, A; Sciutto, C; Van Lint, MT | 1 |
| Calderwood, SB; Jackson, E; Tung, CC | 1 |
| Asari, S; Hayashi, C; Horikawa, M; Koda, K; Miyai, K; Shimizu, Y; Tsukamoto, H | 1 |
| Cavallo, JD; Chevalier, B; Meyran, M | 1 |
| Hu, W; Li, J; Miao, J | 1 |
| Pasiukov, VV; Ryzhko, IV; Samokhodkina, ED; Shcherbaniuk, AI; Tsuraeva, RI | 1 |
| Chen, DK; Chen, YF; Gu, JM; Hou, J; Hu, WZ; Jia, YX; Li, JT; Li, LJ; Liu, DM; Lu, Y; Miao, JZ; Sun, L; Wang, HL; Wang, Z; Wu, J; Zhang, XZ; Zhang, YL | 1 |
| Doern, GV; Jones, RN; Pfaller, MA; Salazar, JC | 1 |
| Bhathena, HM; Kavarana, NM | 1 |
| Chen, X; Sun, Z; Xu, W | 1 |
| Hájek, V; Kolár, M; Látal, T | 1 |
| Samsygina, GA | 1 |
| Arndt, PA; Garratty, G | 1 |
| Lee, WS; Lin, ML; Liu, CY; Wang, FD | 1 |
| Andrasi, M; Buglyo, P; Gaspar, A; Zekany, L | 1 |
| Beksaç, MS; Katlan, D; Kir, S; Nemutlu, E | 1 |
| Dai, J; Huang, H; Li, M; Liao, LC; Liu, XM; Ma, XN; Sheng, X; Su, G; Yan, YY; Yang, L | 1 |
| Chen, D; Song, Z; Wang, Z | 1 |
| Chitnis, DS; Chitnis, S; Hemvani, N; Katara, G | 1 |
7 review(s) available for cefoperazone and cefotaxime
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The cephalosporin antibiotic agents--III. Third-generation cephalosporins.
Topics: Cefmenoxime; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Humans; Moxalactam | 1985 |
Gram-positive superinfections following beta-lactam chemotherapy: the significance of the enterococcus.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cefotaxime; Ceftazidime; Gram-Positive Bacteria; Humans; Imipenem; Moxalactam; Penicillin Resistance; Penicillins; Streptococcus; Thienamycins | 1985 |
Antipseudomonal beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Stability; Lactams; Moxalactam; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1981 |
Pharmacokinetics of the new cephalosporins.
Topics: Cefaclor; Cefadroxil; Cefamandole; Cefazolin; Cefmetazole; Cefonicid; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalexin; Cephalosporins; Cephamycins; Cephradine; Humans; Intestinal Absorption; Kinetics; Moxalactam; Tissue Distribution | 1982 |
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefmenoxime; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Moxalactam | 1982 |
Third-generation and investigational cephalosporins: II. Microbiologic review and clinical summaries.
Topics: Bacteria; Bacterial Infections; Bacteroides fragilis; Cefamandole; Cefoperazone; Cefotaxime; Cefotiam; Cephalosporins; Enterobacteriaceae; Haemophilus influenzae; Humans; Moxalactam; Pseudomonas aeruginosa | 1983 |
18 trial(s) available for cefoperazone and cefotaxime
| Article | Year |
|---|---|
Relationship between vitamin K1 2,3-epoxide and vitamin K1 in patients treated with N-methyl-thiotetrazole cephalosporins.
Topics: Cefoperazone; Cefotaxime; Humans; Middle Aged; Moxalactam; Urinary Tract Infections; Vitamin K 1 | 1992 |
[In vitro activity of beta-lactam antibiotics in combination with sulbactam against enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter. Results of a multicenter study].
Topics: Acinetobacter; Cefoperazone; Cefotaxime; Ceftazidime; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enterobacteriaceae; Humans; In Vitro Techniques; Mezlocillin; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Ticarcillin | 1991 |
[Hemostasis disturbance caused by cephalosporins with an N-methylthiotetrazole side chain. A randomized pilot study].
Topics: Aged; Aged, 80 and over; Azoles; Blood Coagulation Disorders; Cefoperazone; Cefotaxime; Cephalosporins; Female; Humans; Male; Moxalactam; Pilot Projects; Protein C; Prothrombin Time; Random Allocation; Tetrazoles; Urinary Tract Infections; Vitamin K Deficiency | 1989 |
Prophylactic antibiotics for patients undergoing elective biliary tract surgery: a prospective randomized study of cefotiam and cefoperazone.
Topics: Adult; Aged; Biliary Tract Surgical Procedures; Cefoperazone; Cefotaxime; Cefotiam; Diarrhea; Drug Eruptions; Female; Humans; Male; Middle Aged; Premedication; Prospective Studies; Random Allocation; Surgical Wound Infection | 1987 |
[Clinical assessment of sulbactam/cefoperazone in comparison with ceftizoxime in patients with postoperative infections by well controlled method].
Topics: Adolescent; Adult; Aged; beta-Lactamase Inhibitors; Cefoperazone; Cefotaxime; Ceftizoxime; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Penicillanic Acid; Sulbactam; Surgical Wound Infection | 1985 |
Antibiotic use during major head and neck surgery.
Topics: Anti-Bacterial Agents; Cefazolin; Cefoperazone; Cefotaxime; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Gentamicins; Head and Neck Neoplasms; Humans; Moxalactam; Premedication; Prospective Studies; Random Allocation | 1988 |
Single-dose cephalosporin prophylaxis of 929 surgical procedures in a prepaid group practice: a prospective, randomized comparison of cefoperazone and cefotaxime.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefoperazone; Cefotaxime; Costs and Cost Analysis; Female; Health Maintenance Organizations; Humans; Male; Middle Aged; Pneumonia; Postoperative Complications; Premedication; Prospective Studies; Random Allocation; Surgical Wound Infection; Urinary Tract Infections | 1987 |
Randomized, prospective, and double-blind trial of new beta-lactams in the treatment of appendicitis.
Topics: Anti-Bacterial Agents; Appendectomy; Cefoperazone; Cefotaxime; Child; Clinical Trials as Topic; Double-Blind Method; Humans; Kinetics; Moxalactam; Premedication; Prospective Studies; Random Allocation; Surgical Wound Infection | 1985 |
The effects of latamoxef, cefotaxime, and cefoperazone on platelet function and coagulation in normal volunteers.
Topics: Blood Coagulation; Blood Platelets; Cefoperazone; Cefotaxime; Humans; Moxalactam; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time | 1985 |
Comparative pharmacokinetics of cefoperazone and cefotaxime.
Topics: Adult; Cefoperazone; Cefotaxime; Cephalosporins; Female; Humans; Infusions, Parenteral; Kinetics; Male; Middle Aged | 1980 |
Third-generation cephalosporins for polymicrobial surgical sepsis.
Topics: Abscess; Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Child; Clindamycin; Clinical Trials as Topic; Female; Gentamicins; Humans; Kidney Diseases; Male; Middle Aged; Moxalactam; Peritoneal Diseases; Peritonitis; Postoperative Complications; Random Allocation; Surgical Wound Infection | 1983 |
Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.
Topics: Adult; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Moxalactam | 1983 |
Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
Topics: Adolescent; Alcohol Deterrents; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Cephalosporins; Child; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Eosinophilia; Humans; Moxalactam; Penicillins; Piperacillin; Pseudomonas Infections; Random Allocation; Respiratory Tract Infections | 1983 |
Efficacy of two third-generation cephalosporins in prophylaxis for head and neck surgery.
Topics: Bacteria; Cefoperazone; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Head and Neck Neoplasms; Humans; Kinetics; Premedication; Surgical Wound Infection | 1984 |
Experience with the third generation cephalosporins, cefoperazone and cefotaxime: report.
Topics: Adolescent; Adult; Aged; Ampicillin; Bacterial Infections; Cefoperazone; Cefotaxime; Clinical Trials as Topic; Cloxacillin; Female; Gentamicins; Humans; Male; Middle Aged; Random Allocation; Ticarcillin; Vitamin K | 1984 |
[A randomized controlled clinical trial of sulperazone as compared with cefotaxime in the treatment of bacterial infections].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cefotaxime; Drug Combinations; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sulbactam | 1995 |
Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Skin Diseases, Bacterial; Sulbactam; Urinary Tract Infections | 1997 |
Prophylactic antibiotics administration head and neck cancer surgery with major flap reconstruction: 1-day cefoperazone versus 5-day cefotaxime.
Topics: Antibiotic Prophylaxis; Cefoperazone; Cefotaxime; Cephalosporins; Double-Blind Method; Head and Neck Neoplasms; Humans; Prospective Studies; Surgical Flaps; Surgical Wound Infection; Treatment Outcome | 1998 |
156 other study(ies) available for cefoperazone and cefotaxime
| Article | Year |
|---|---|
Dual-action cephalosporins: cephalosporin 3'-quinolone carbamates.
Topics: Animals; Anti-Bacterial Agents; Carbamates; Cefotaxime; Cephalosporins; Chromatography, High Pressure Liquid; Ciprofloxacin; Escherichia coli; Mice; Pseudomonas aeruginosa; Spectrophotometry, Infrared; Staphylococcus aureus; Streptococcus pneumoniae | 1991 |
Dual-action cephalosporins incorporating a 3'-tertiary-amine-linked quinolone.
Topics: beta-Lactamases; Cephalosporins; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Resistance, Microbial; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; Molecular Structure; Nitrogen; Quinolines; Structure-Activity Relationship | 1994 |
Interaction of human organic anion transporters with various cephalosporin antibiotics.
Topics: Animals; Biological Transport; Cefadroxil; Cefotaxime; Ceftriaxone; Cell Line; Cephaloridine; Cephalosporins; Cephalothin; Estrone; Humans; Kinetics; Liver-Specific Organic Anion Transporter 1; Mice; Mice, Transgenic; Organic Anion Transport Protein 1; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Tritium | 2002 |
Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: in comparison with rOAT1.
Topics: Animals; Cephaloridine; Cephalosporins; Immunohistochemistry; Kidney; Mice; Organic Anion Transporters, Sodium-Independent; Rats | 2002 |
Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biological Transport; Cefadroxil; Cefamandole; Cefazolin; Cefoperazone; Cefotaxime; Ceftriaxone; Cell Line; Cell Survival; Cephaloridine; Cephalosporins; Cephalothin; Dinoprost; Dose-Response Relationship, Drug; Humans; Kinetics; Mice; Mice, Transgenic; Organic Anion Transporters, Sodium-Independent; Probenecid; Rats; Transfection; Uricosuric Agents | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Biochemical characterization of PER-2 and genetic environment of blaPER-2.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Catalysis; Citrobacter freundii; Conjugation, Genetic; DNA, Bacterial; DNA, Recombinant; Enterobacteriaceae; Genes, Bacterial; Humans; Hydrolysis; Isoelectric Focusing; Kinetics; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Conformation; Protein Sorting Signals; Sequence Analysis, DNA | 2007 |
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
Induction of L1 and L2 beta-lactamases of Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Catechol 2,3-Dioxygenase; Enzyme Induction; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Sequence Analysis, DNA; Stenotrophomonas maltophilia | 2008 |
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |
Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; China; Conjugation, Genetic; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Hospitals, University; Humans; Hydrolysis; Intensive Care Units; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Serratia marcescens | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
Topics: Amino Acid Sequence; beta-Lactamases; Blotting, Southern; Ceftazidime; Cephalosporins; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Shigella sonnei | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Susceptibilities of 23 Desulfovibrio isolates from humans.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Desulfovibrio; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.
Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis; Republic of Korea | 2010 |
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacitracin; Bacterial Proteins; beta-Lactam Resistance; Listeria monocytogenes; Nisin | 2010 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Cell Line, Transformed; Humans; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Solubility; Structure-Activity Relationship | 2013 |
The patterns and transmissibility of antibiotic resistance among clinical strains of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Conjugation, Genetic; Drug Resistance, Microbial; Phenotype; Pseudomonas aeruginosa; R Factors; Tetracycline | 1992 |
Effect of ceftazidime, cefotaxime, and cefoperazone on serum tobramycin concentrations.
Topics: Cefoperazone; Cefotaxime; Ceftazidime; Drug Interactions; Humans; Tobramycin | 1991 |
Comparative susceptibility studies of clinically isolated Pseudomonas aeruginosa, Escherichia coli and Klebsiella spp to cefoperazone and cefotaxime.
Topics: Cefoperazone; Cefotaxime; Drug Resistance, Microbial; Escherichia coli; Klebsiella; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1990 |
[A study of prostatic tissue levels of latamoxef, cefoperazone and cefotaxime].
Topics: Aged; Aged, 80 and over; Biological Transport; Cefoperazone; Cefotaxime; Chromatography, High Pressure Liquid; Humans; Male; Middle Aged; Moxalactam; Premedication; Prostate; Prostatectomy; Prostatic Hyperplasia | 1986 |
Comparative in vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
Topics: Aztreonam; Cefoperazone; Cefotaxime; Ceftazidime; Cross Infection; Gentamicins; Gram-Negative Bacteria; Moxalactam; Ticarcillin | 1989 |
The influence of cefoperazone, cefotaxime, ceftazidime and aztreonam on phagocytosis by human neutrophils in vitro.
Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; Cefoperazone; Cefotaxime; Ceftazidime; Escherichia coli; Humans; In Vitro Techniques; Neutrophils; Phagocytosis; Proteins | 1989 |
Penetration of third-generation cephalosporins into human peritoneal tissue.
Topics: Ascitic Fluid; Bacteroides fragilis; Cefoperazone; Cefotaxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Peritoneum; Tissue Distribution | 1989 |
[Comparison between cefoperazone and cefotaxime in the treatment of infections of the lower respiratory tract].
Topics: Adolescent; Adult; Aged; Cefoperazone; Cefotaxime; Drug Evaluation; Female; Humans; Male; Middle Aged; Respiratory Tract Infections | 1987 |
Correlation of predicted serum bactericidal activities and values measured in volunteers.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Drug Evaluation; Escherichia coli; Humans; Klebsiella pneumoniae; Male; Moxalactam; Pseudomonas aeruginosa; Staphylococcus aureus | 1986 |
In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida.
Topics: Cefaclor; Cefixime; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephalothin; Cloxacillin; Erythromycin; Humans; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Pasteurella; Penicillin G; Penicillin V | 1986 |
Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam.
Topics: Anti-Bacterial Agents; Aztreonam; Cefoperazone; Cefotaxime; Ceftazidime; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa | 1986 |
In vitro activity of BMY-28142, a new cephalosporin.
Topics: Bacteria; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus | 1987 |
Biological activity of BO-1236, a new antipseudomonal cephalosporin.
Topics: Animals; Bacterial Infections; beta-Lactamases; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Chemical Phenomena; Chemistry; Gram-Negative Bacteria; Gram-Positive Bacteria; Isoindoles; Male; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1987 |
In vitro activity of desacetylcefotaxime and the interaction with its parent compound, cefotaxime.
Topics: Bacteria; Cefoperazone; Cefotaxime; Ceftazidime; Drug Antagonism; Drug Synergism; Enterobacter; Escherichia coli; Humans; Klebsiella pneumoniae; Pseudomonas aeruginosa; Staphylococcus aureus | 1988 |
In vitro activity of cefotaxime against clinically significant pathogens.
Topics: beta-Lactamases; Cefamandole; Cefazolin; Cefoperazone; Cefotaxime; Drug Resistance, Microbial; Enterobacteriaceae; Micrococcaceae; Staphylococcus; Streptococcus | 1988 |
[Changes in the phagocytic activity of human polymorphonuclear neutrophils induced in vitro by cefotiam vs 6 other antibiotics].
Topics: Adult; Cefoperazone; Cefotaxime; Cefotiam; Ceftazidime; Cephalosporins; Female; Gentamicins; Humans; Luminescent Measurements; Male; Middle Aged; Neutrophils; Phagocytosis; Piperacillin; Rifampin | 1987 |
Paradoxical antibacterial activity of cefmenoxime against Proteus vulgaris.
Topics: beta-Lactamases; Cefmenoxime; Cefoperazone; Cefotaxime; Cephamycins; Drug Resistance, Microbial; Enzyme Induction; Microbial Sensitivity Tests; Proteus vulgaris | 1987 |
[Susceptibility of some bacteria isolated from clinical samples to third-generation cephalosporins].
Topics: Bacteria; Cefoperazone; Cefotaxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Escherichia coli; Humans; Klebsiella; Proteus; Pseudomonas; Staphylococcus aureus; Staphylococcus epidermidis | 1987 |
Transcervical amnioinfusion of antibiotics: a basic study for managing premature rupture of membranes.
Topics: Amnion; Anti-Bacterial Agents; Catheterization; Cefoperazone; Cefotaxime; Cervix Uteri; Chorioamnionitis; Female; Fetal Membranes, Premature Rupture; Humans; Moxalactam; Pregnancy | 1988 |
[Antibiotic activities of cefuzoname and the representative cephalosporins against clinically isolated methicillin resistant strains of Staphylococcus].
Topics: Cefamandole; Cefazolin; Cefoperazone; Cefotaxime; Cefotiam; Ceftizoxime; Cephalosporins; Drug Resistance; In Vitro Techniques; Methicillin; Staphylococcus aureus; Staphylococcus epidermidis | 1986 |
[Susceptibility of clinical isolates to aztreonam].
Topics: Aztreonam; Cefmetazole; Cefoperazone; Cefotaxime; Cefsulodin; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1987 |
Protein binding of ceftriaxone, cefoperazone, and ceftizoxime.
Topics: Adult; Cefoperazone; Cefotaxime; Ceftizoxime; Ceftriaxone; Female; Humans; Male; Protein Binding; Reference Values | 1987 |
Cefoxitin sensitivity as a marker for inducible beta-lactamases.
Topics: beta-Lactamases; Cefoperazone; Cefotaxime; Cefoxitin; Drug Resistance, Microbial; Enterobacteriaceae; Enzyme Induction; Gram-Negative Bacteria; Microbial Sensitivity Tests; Moxalactam; Pseudomonas | 1986 |
In-vitro antibacterial activity of L-105, a new cephalosporin.
Topics: beta-Lactamases; Cefazolin; Cefmenoxime; Cefoperazone; Cefotaxime; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rifamycins; Rifaximin | 1986 |
Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria.
Topics: Bacteria, Aerobic; Bacteroides fragilis; beta-Lactamase Inhibitors; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Microbial Sensitivity Tests; Sulbactam | 1987 |
Evaluation of broth disk elution methods for susceptibility testing of anaerobic bacteria with the newer beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroidaceae; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Ceftizoxime; Clostridium; Evaluation Studies as Topic; Microbial Sensitivity Tests; Moxalactam; Piperacillin | 1986 |
Therapeutic effect of SF-2103A, a novel carbapenem antibiotic, in combination with cefotaxime, cefoperazone and other cephalosporins.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefoperazone; Cefotaxime; Cephalosporins; Drug Stability; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Kinetics; Proteus Infections; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1986 |
In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem.
Topics: Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Piperacillin; Thienamycins; Tobramycin | 1986 |
Effect of the topical application of some newer antibiotics on the cerebral cortex.
Topics: Animals; Anti-Bacterial Agents; Bacitracin; Cats; Cefoperazone; Cefotaxime; Cerebral Cortex; Metronidazole; Moxalactam; Piperacillin | 1987 |
Cefpirome (HR810) disk diffusion susceptibility tests: confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented media.
Topics: Bacteria; Blood; Cefoperazone; Cefotaxime; Cefpirome; Cephalosporins; Culture Media; Diffusion; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Species Specificity | 1986 |
Pharmacokinetics of cefotaxime, moxalactam, and cefoperazone in the early puerperium.
Topics: Adult; Cefoperazone; Cefotaxime; Female; Humans; Injections, Intravenous; Kinetics; Moxalactam; Postpartum Period; Pregnancy | 1986 |
Predicting the susceptibility of anaerobes to cefoperazone, cefotaxime, and cefoxitin with the thioglycolate broth disk procedure.
Topics: Bacteria, Anaerobic; Bacteroides fragilis; Cefoperazone; Cefotaxime; Cefoxitin; Drug Resistance, Microbial; False Negative Reactions; False Positive Reactions; Microbial Sensitivity Tests | 1986 |
The effect of control on the pattern of utilization of cefotaxime, moxalactam and cefoperazone in a teaching hospital.
Topics: Bacterial Infections; Cefoperazone; Cefotaxime; Hospitals, Teaching; Humans; Medical Records; Moxalactam; Pharmacy Service, Hospital; Premedication; Retrospective Studies | 1985 |
Comparative in vitro and in vivo activity of cefminox (MT-141), cefotaxime and cefoperazone against gram-negative bacteria.
Topics: Animals; Bacterial Infections; Cefoperazone; Cefotaxime; Cephamycins; Female; Gram-Negative Bacteria; Humans; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Proteus; Proteus Infections | 1985 |
Studies of cefotaxime serum concentrations during surgery under general anaesthesia and its passage to the wound fluid after surgery for breast cancer.
Topics: Anesthesia, General; Breast; Breast Neoplasms; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Ceftizoxime; Ceftriaxone; Cephamycins; Exudates and Transudates; Female; Humans; Mastectomy; Premedication | 1985 |
[Studies on specific IgE antibody against side chain of beta-lactam antibiotics and the modified PCA inhibition test as a new measurement method].
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Cefmetazole; Cefoperazone; Cefotaxime; Ceftizoxime; Cephamycins; Chromatography, Thin Layer; Guinea Pigs; Immunoglobulin E; Male; Passive Cutaneous Anaphylaxis | 1985 |
Beta-lactamase-positive strains of Haemophilus influenzae: susceptibility to and inactivation of beta-lactam antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefamandole; Cefoperazone; Cefotaxime; Ceftriaxone; Haemophilus influenzae; Mezlocillin; Microbial Sensitivity Tests; Moxalactam | 1985 |
The activity of cefbuperazone, a 7 alpha-methoxy 7 beta acyl ureido cephalosporin.
Topics: Bacteria; beta-Lactamases; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Cephamycins; Hydrolysis; Microbial Sensitivity Tests; Moxalactam; Piperacillin | 1985 |
Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Biological Availability; Blood Proteins; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Male; Mice; Microbial Sensitivity Tests; Moxalactam; Protein Binding | 1985 |
Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.
Topics: Bacteria; beta-Lactamases; Cefepime; Cefoperazone; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Drug Stability; Hydrolysis; Microbial Sensitivity Tests | 1985 |
Role of cephalosporins in the treatment of bacterial meningitis in adults. Overview with special emphasis on ceftazidime.
Topics: Adult; Animals; Bacterial Infections; Cefoperazone; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Disease Models, Animal; Humans; Meningitis | 1985 |
[In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
Topics: Cefoperazone; Cefotaxime; Cefotetan; Cefotiam; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria | 1985 |
Pharmacokinetic properties of the newer cephalosporins. A valid basis for drug selection?
Topics: Bile; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Half-Life; Humans; Kinetics; Moxalactam | 1985 |
[Comparison of in vitro antibacterial activities of new cephems against clinical organisms (isolated between June 1983 and January 1984)].
Topics: Bacteria; Cefmenoxime; Cefoperazone; Cefotaxime; Cefotetan; Ceftazidime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests | 1985 |
Assessment of serum bactericidal activity after administration of cefoperazone, cefotaxime, ceftizoxime, and moxalactam to healthy subjects.
Topics: Adult; Anti-Bacterial Agents; Bacillus subtilis; Cefoperazone; Cefotaxime; Ceftizoxime; Escherichia coli; Female; Humans; Male; Moxalactam; Staphylococcus aureus | 1985 |
Interaction of third generation cephalosporins combined with amikacin against Pseudomonas aeruginosa.
Topics: Amikacin; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Drug Synergism; Kanamycin; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa | 1985 |
Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures.
Topics: Cefmenoxime; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis | 1985 |
[Studies on the combination action of sisomicin, gentamicin and cefmenoxime, ceftizoxime, cefoperazone, cefotetan against Serratia marcescens and Pseudomonas aeruginosa].
Topics: Cefmenoxime; Cefoperazone; Cefotaxime; Cefotetan; Ceftizoxime; Cephamycins; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Pseudomonas aeruginosa; Serratia marcescens; Sisomicin | 1985 |
Effect of formulary restriction of cefotaxime usage.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefoperazone; Cefotaxime; Child; Child, Preschool; Drug Utilization; Female; Formularies, Hospital as Topic; Humans; Infant; Male; Medicine; Middle Aged; Moxalactam; Retrospective Studies; Specialization; Specialties, Surgical | 1985 |
[Third generation cephalosporins in severe infections in children].
Topics: Bacterial Infections; Cefoperazone; Cefotaxime; Ceftriaxone; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male | 1985 |
Pharmacokinetics of cefaronide, ceftriaxone and cefoperazone in sheep.
Topics: Animals; Cefamandole; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Female; Injections, Intravenous; Kinetics; Sheep; Spectrophotometry, Ultraviolet | 1985 |
In vitro comparative antimicrobial activity of cefpimizole against clinical isolates from five medical centers.
Topics: Bacteria; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests | 1985 |
The influence of third-generation cephalosporins on the aerobic intestinal flora.
Topics: Bacteria, Aerobic; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Feces; Humans; Infant; Intestines | 1985 |
[A study of prostatic tissue levels of ceftizoxime, cefoperazone and cefotaxime].
Topics: Aged; Cefoperazone; Cefotaxime; Ceftizoxime; Humans; Male; Prostate; Prostatic Hyperplasia | 1984 |
Lack of interference with creatinine assays by four cephalosporin-like antibiotics.
Topics: Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Creatinine; False Positive Reactions; Humans; Moxalactam | 1984 |
In vitro antibacterial activity and beta-lactamase stability of cefodizime, a new cephalosporin antibiotic.
Topics: Cefoperazone; Cefotaxime; Escherichia coli; Haemophilus influenzae; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Staphylococcus aureus | 1984 |
Hepatic hematoma after blunt trauma--a case of nonoperative management to prevent liver abscess formation.
Topics: Adolescent; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cephalothin; Cephamycins; Dibekacin; Hematoma; Humans; Injections, Intra-Arterial; Liver; Liver Abscess; Liver Diseases; Male; Wounds, Nonpenetrating | 1984 |
Diffusibility of the newer cephalosporins into human interstitial fluids.
Topics: Adolescent; Adult; Blood Proteins; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Diffusion; Extracellular Space; Humans; Male; Middle Aged; Moxalactam; Protein Binding | 1984 |
A comparison of cefotaxime and cefoperazone in respiratory tract infections.
Topics: Adult; Aged; Bacteria; Cefoperazone; Cefotaxime; Female; Humans; Male; Middle Aged; Respiratory Tract Infections | 1984 |
Influence of third-generation cephalosporins on aerobic intestinal flora.
Topics: Bacteria, Aerobic; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Feces; Humans; Infant; Intestines | 1984 |
[The third generation cephems for surgical infections].
Topics: Cefmenoxime; Cefoperazone; Cefotaxime; Ceftizoxime; Drug Evaluation; Humans; Moxalactam; Surgical Wound Infection | 1984 |
Activity of some antibiotics against Pseudomonas aeruginosa strains isolated from cancerous patients.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftazidime; Drug Resistance, Microbial; Humans; Neoplasms; Pseudomonas aeruginosa; Pseudomonas Infections | 1984 |
The serum bactericidal activity of latamoxef (moxalactam), cefoperazone and cefotaxime.
Topics: Adolescent; Adult; Bacteria; Cefoperazone; Cefotaxime; Humans; Male; Microbial Sensitivity Tests; Moxalactam; Neutropenia | 1984 |
Comparative pharmacokinetics of four new cephalosporins: moxalactam, cefotaxime, cefoperazone and ceftazidime in neonates.
Topics: Cefoperazone; Cefotaxime; Ceftazidime; Half-Life; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kinetics; Moxalactam | 1984 |
In vitro susceptibility tests with cefoperazone compared with cefotaxime, cefoxitin, cefuroxime, cephaloridine and gentamicin.
Topics: Bacteria; Cefoperazone; Cefotaxime; Cefoxitin; Cefuroxime; Cephaloridine; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1984 |
[Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
Topics: Bacteria; Cefazolin; Cefoperazone; Cefotaxime; Cefoxitin; Cefuroxime; Cephacetrile; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Cephradine; Enterobacter; Escherichia coli; Humans; Klebsiella pneumoniae; Salmonella; Staphylococcus aureus | 1982 |
[Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
Topics: Acinetobacter; Bacteria; Cefoperazone; Cefotaxime; Cefoxitin; Cefuroxime; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Streptococcus | 1982 |
In vitro antibacterial activity of E-0702, a new semisynthetic cephalosporin.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefoperazone; Cefotaxime; Cephalosporins; Citrobacter; Enterobacteriaceae; Gram-Negative Bacteria; Microbial Sensitivity Tests; Proteus; Pseudomonas aeruginosa; Salmonella; Serratia | 1982 |
Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefaclor; Cefoperazone; Cefotaxime; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Cephamycins; Culture Media; Microbial Sensitivity Tests; Moxalactam | 1980 |
Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Topics: Bacteria; Cefamandole; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Staphylococcus; Streptococcus; Ticarcillin | 1980 |
In vitro efficacy of cefoperazone compared with cefotaxime, LY127935, and thienamycin.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Lactams; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Thienamycins | 1980 |
Activities of cefoperazone, cefotaxime, cefuroxime, and cephalothin against 128 clinical isolates.
Topics: Cefoperazone; Cefotaxime; Cefuroxime; Cephalosporins; Cephalothin; Enterobacteriaceae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus | 1980 |
In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
Topics: Azlocillin; beta-Lactamases; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Haemophilus influenzae; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins | 1980 |
Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
Topics: Aerobiosis; Bacteria; Blood; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Culture Media; Drug Resistance, Microbial; Humans; Moxalactam; Pseudomonas aeruginosa; Species Specificity; Staphylococcus aureus | 1980 |
Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
Topics: Aminoglycosides; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1980 |
In vitro comparison of three new cephalosporins: LY-127935, cefotaxime and cefoperazone.
Topics: Bacteria; Cefoperazone; Cefotaxime; Cephalosporinase; Cephalosporins; Cephamycins; Drug Interactions; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Moxalactam | 1981 |
Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.
Topics: Ampicillin; Animals; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Escherichia coli; Humans; Kinetics; Listeria monocytogenes; Male; Meningitis; Moxalactam; Penicillin Resistance; Rabbits; Streptococcus agalactiae | 1981 |
Bactericidal activity of antibiotics against Campylobacter fetus subspecies intestinalis.
Topics: Ampicillin; Campylobacter; Campylobacter fetus; Cefoperazone; Cefotaxime; Cephalosporins; Cephalothin; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Streptomycin | 1981 |
Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1980 |
Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.
Topics: Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Ceftriaxone; Cefuroxime; Cephalosporins; Cephalothin; Cephamycins; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Neisseria meningitidis | 1981 |
Pharmacokinetics of cefoperazone, moxalactam, cefotaxime, trimethoprim and sulphamethoxazole in experimental meningitis.
Topics: Animals; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Kinetics; Meningitis; Moxalactam; Rabbits; Sulfamethoxazole; Trimethoprim | 1981 |
Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Cefoperazone; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Synergism; Penicillanic Acid; Sulbactam | 1981 |
In vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone.
Topics: Aerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Humans; Imipenem; Lactams; Penicillins; Piperacillin; Species Specificity | 1981 |
Potential value of cefoperazone in bacterial meningitis: experimental studies.
Topics: Animals; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Kinetics; Meningitis, Haemophilus; Moxalactam; Rabbits | 1981 |
Susceptibility of Pseudomonas aeruginosa to cefoperazone, cefotaxime and moxalactam, with special reference to isolates resistant to aminoglycosides, carbenicillin and ticarcillin.
Topics: Carbenicillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Dose-Response Relationship, Drug; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa; Ticarcillin | 1981 |
Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
Topics: beta-Lactamases; Carbenicillin; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa | 1981 |
Antibacteroides and beta-lactamase inhibitory activities of moxalactam.
Topics: Bacteroides fragilis; beta-Lactamases; Cefoperazone; Cefotaxime; Cefoxitin; Ceftizoxime; Cephalosporins; Cephamycins; In Vitro Techniques; Moxalactam | 1981 |
Comparative in vitro activity of first, second and third generation cephalosporins.
Topics: Bacteria; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Cefuroxime; Cephalosporins; Cephalothin; Cephamycins; Dose-Response Relationship, Drug; Moxalactam; Structure-Activity Relationship | 1981 |
Comparative in vitro activity of ceftizoxime, cefoperazone, and cefoxitin against anaerobic bacteria.
Topics: Anaerobiosis; Bacteria; Cefoperazone; Cefotaxime; Cefoxitin; Ceftizoxime; Cephalosporins; Microbial Sensitivity Tests | 1981 |
Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
Topics: Azlocillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Imipenem; Lactams; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin; Serratia marcescens | 1981 |
The new cephalosporins and penicillins.
Topics: Azlocillin; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Mezlocillin; Moxalactam; Penicillins; Piperacillin | 1982 |
Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
Topics: Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin | 1982 |
Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
Topics: Animals; Cefoperazone; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephamycins; Dose-Response Relationship, Drug; Infusions, Parenteral; Kinetics; Male; Meningitis, Haemophilus; Meningitis, Pneumococcal; Moxalactam; Rabbits; Streptococcus pneumoniae | 1982 |
Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam.
Topics: Anti-Bacterial Agents; Azlocillin; Bacteria; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Drug Synergism; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillins | 1982 |
Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Imipenem; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections | 1981 |
The comparative activities of N-formimidoyl theinamycin (MK0787), moxalactam, cefotaxime and cefoperazone against Yersinia enterocolitica and Listeria monocytogenes.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Listeria monocytogenes; Moxalactam; Yersinia | 1982 |
[Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
Topics: Bacteria; Cefazolin; Cefmenoxime; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Gentamicins; Moxalactam; Structure-Activity Relationship | 1982 |
[Efficacy of the new cephalosporin antibiotics cefotaxime, cefoperazone and lamoxactam].
Topics: Bacteria; Cefazolin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Microbial Sensitivity Tests; Moxalactam | 1982 |
In vitro susceptibility of Clostridium difficile isolates to cefotaxime, moxalactam, and cefoperazone.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Clostridium; Microbial Sensitivity Tests; Moxalactam | 1982 |
[Statistical regression analysis for four new cephalosporins (author's transl)].
Topics: Bacteria; Cefoperazone; Cefotaxime; Cefotiam; Cephalosporins; Cephamycins; Microbial Sensitivity Tests; Moxalactam; Regression Analysis | 1982 |
[Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
Topics: Bacteria; beta-Lactamases; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Gentamicins; Microbial Sensitivity Tests; Moxalactam | 1982 |
Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbenicillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Drug Synergism; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa; Tobramycin | 1981 |
Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Humans; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin | 1982 |
[Cephem antibiotics and alcohol metabolism: (1) Disulfiram-like reaction resulting from intravenous administration of cephem antibiotics].
Topics: Acetaldehyde; Administration, Oral; Animals; Cefamandole; Cefazolin; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Cephamycins; Disulfiram; Drug Interactions; Ethanol; Injections, Intravenous; Male; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1982 |
Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin and cephalothin for 118 strains of Haemophilus influenzae including 'tolerant' micro-organisms.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephalothin; Cephamycins; Haemophilus influenzae; Microbial Sensitivity Tests; Moxalactam | 1982 |
Comparative pharmacokinetics of ceftizoxime and other third-generation cephalosporins in humans.
Topics: Adolescent; Adult; Aged; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Cephamycins; Humans; Kinetics; Middle Aged; Models, Biological; Moxalactam; Myelography; Protein Binding; Time Factors | 1982 |
[The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
Topics: Bacteria; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Enterobacter; Haemophilus influenzae; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Proteus; Streptococcus pneumoniae | 1983 |
Ceftriaxone--and more to come.
Topics: Bacterial Infections; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Child; Humans; Microbial Sensitivity Tests; Moxalactam | 1983 |
Lack of interference of five new beta-lactam antibiotics with serum creatinine determination.
Topics: Anti-Bacterial Agents; Autoanalysis; Aztreonam; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Creatinine; Humans; Male | 1983 |
In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Synergism; Imipenem; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins | 1983 |
Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks.
Topics: Acinetobacter; Bacteria; beta-Lactamases; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Ceftriaxone; Cell Membrane Permeability; Drug Resistance, Microbial; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Moxalactam; Neisseria; Pseudomonas; Staphylococcus aureus; Streptococcus | 1983 |
Beta-lactamase stability of cefoxitin in comparison with other beta-lactam compounds.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbenicillin; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporinase; Gram-Negative Bacteria; Moxalactam; Penicillinase; Piperacillin | 1983 |
Entry of four cephalosporins into the ovine lung.
Topics: Albumins; Animals; Binding, Competitive; Blood Proteins; Cefazolin; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Female; Humans; Lung; Lymph; Moxalactam; Proteins; Sheep | 1984 |
Comparative study on the interstitial passage of cefuroxime, cefoxitin, cefotaxime and cefoperazone in man by the suction skin blister method.
Topics: Adult; Aged; Blister; Body Fluids; Cefoperazone; Cefotaxime; Cefoxitin; Cefuroxime; Cephalosporins; Female; Humans; Kinetics; Male; Middle Aged; Skin; Tissue Distribution | 1983 |
Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefoperazone; Cefotaxime; Cefotetan; Cefoxitin; Ceftriaxone; Cell Membrane Permeability; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1983 |
[Comparative activity of azlocillin on Pseudomonas species excluding Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Cefsulodin; Cephalosporins; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas; Pseudomonas fluorescens | 1984 |
[In vivo antibacterial activity of cefoperazone in intraperitoneal infections in mice].
Topics: Animals; Ascitic Fluid; Bacteria; beta-Lactamases; Cefoperazone; Cefotaxime; Cefotiam; Drug Evaluation, Preclinical; Male; Mice; Peritonitis | 1983 |
[In vivo effects of cefoperazone in local infection].
Topics: Abscess; Animals; Bacterial Infections; Cefoperazone; Cefotaxime; Cefotiam; Drug Evaluation, Preclinical; Male; Mice; Rats | 1983 |
Mechanisms of beta-lactam resistance in British isolates of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Azlocillin; beta-Lactamases; Carbenicillin; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Chromosomes, Bacterial; Isoelectric Point; Penicillin Resistance; Penicillins; Plasmids; Pseudomonas aeruginosa; United Kingdom | 1984 |
Cefoperazone versus cefotaxime, plus amikacin or sisomicin, in fever and infection in hematologic granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anemia, Aplastic; Cefoperazone; Cefotaxime; Drug Therapy, Combination; Female; Fever; Humans; Immunosuppression Therapy; Infections; Kanamycin; Leukemia; Male; Middle Aged; Random Allocation; Sisomicin | 1984 |
Measurement of levels of aminoglycosides and vancomycin in serum in the presence of new beta-lactam antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Humans; Immunoenzyme Techniques; Mezlocillin; Moxalactam; Penicillins; Piperacillin; Vancomycin | 1984 |
[Susceptibility of clinical isolates to cefotaxime. Comparison to new antibiotics latamoxef, cefoperazone, and ceftizoxime].
Topics: Bacteria; Cefoperazone; Cefotaxime; Ceftizoxime; Drug Resistance, Microbial; Moxalactam; Sputum; Suppuration; Urine | 1984 |
[Bactericidal activity of 6 antibiotics and 3 combinations against 6 strains of Salmonella isolated from blood].
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftriaxone; Chloramphenicol; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; In Vitro Techniques; Salmonella | 1995 |
[Third generation cephalosporins (cefoperazone, cefotaxime, ceftazidime and ceftriaxone) in the prevention and treatment of experimental plague in albino mice].
Topics: Animals; Cefoperazone; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Evaluation, Preclinical; Mice; Microbial Sensitivity Tests; Plague; Treatment Outcome; Yersinia pestis | 1996 |
Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporinase; Cephalosporins; Cohort Studies; Colombia; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Reproducibility of Results; Staphylococcus; Sulbactam | 1997 |
[An analysis of bacterial resistance to antimicrobial agents in a burn centre].
Topics: Burns; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Humans; Pseudomonas aeruginosa; Wound Infection | 1998 |
Development of bacterial resistance to the third generation cephalosporins and their clinical use.
Topics: Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Czech Republic; Gram-Negative Bacteria; Hospitals; Humans | 1999 |
[Cephalosporins of the third generation in therapy of children with severe infections].
Topics: Adolescent; Cefoperazone; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Hospital Bed Capacity, 500 and over; Humans; Infant; Infant, Newborn; Infections | 2000 |
Cross-reactivity of cefotetan and ceftriaxone antibodies, associated with hemolytic anemia, with other: cephalosporins and penicillin.
Topics: Anemia, Hemolytic; Antibodies; Cefamandole; Cefoperazone; Cefotaxime; Cefotetan; Cefoxitin; Ceftriaxone; Cells, Cultured; Cephalosporins; Cephalothin; Cross Reactions; Humans; Models, Chemical; Penicillins | 2002 |
In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
Topics: Acinetobacter baumannii; Ampicillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serratia marcescens; Sulbactam | 2004 |
A comparative study of capillary zone electrophoresis and pH-potentiometry for determination of dissociation constants.
Topics: Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cefoperazone; Cefotaxime; Cefoxitin; Cephalexin; Cephalosporins; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Kinetics; Molecular Structure; Potentiometry | 2007 |
Simultaneous multiresponse optimization of an HPLC method to separate seven cephalosporins in plasma and amniotic fluid: application to validation and quantification of cefepime, cefixime and cefoperazone.
Topics: Amniotic Fluid; Calibration; Cefepime; Cefixime; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Drug Stability; Female; Humans; Molecular Structure; Pregnancy; Reproducibility of Results; Temperature | 2009 |
[Analysis of multiple cephalosporins in blood and urine by HPLC].
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Cefoperazone; Cefotaxime; Cephalosporins; Cephradine; Chromatography, High Pressure Liquid; Forensic Toxicology; Humans; Male; Sensitivity and Specificity; Specimen Handling | 2009 |
Study on the binding behavior of bovine serum albumin with cephalosporin analogues by chemiluminescence method.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cefaclor; Cefadroxil; Cefazolin; Cefoperazone; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Luminescence; Luminescent Measurements; Phthalic Acids; Serum Albumin, Bovine; Thermodynamics; Tryptophan | 2010 |
Augmentation in zone of inhibition of cefoperazone/cefoperazone+ sulbactum compares well with the clinical laboratory standard institute standard extended spectrum beta-lactamase detection method as well as the polymerase chain reaction method.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefoperazone; Cefotaxime; Ceftazidime; Clavulanic Acid; Drug Combinations; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sulbactam | 2011 |